Primary Care POC Diagnostics Market Poised to Hit $23.86 Billion by 2029 with Accelerating Growth Trends

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Primary Care POC Diagnostics Market Size Growth Forecast: What to Expect by 2025?
In recent years, there has been a robust expansion in the size of the primary care POC diagnostics market. From 2024 to 2025, it is projected to grow from a value of $16.46 billion to $17.78 billion at a compound annual growth rate (CAGR) of 8.0%. Factors contributing to this growth during the historical period include an increase in chronic disease prevalence, a shift towards personalized medicine, greater healthcare expenditure, improved regulatory frameworks and streamlined approval processes, and a focus on early detection and disease prevention methods.

How Will the Primary Care POC Diagnostics Market Size Evolve and Grow by 2029?
Over the next few years, the primary care POC diagnostics market is predicted to experience robust growth, reaching a market size of $23.86 billion in 2029 with a 7.6% compound annual growth rate (CAGR). Factors contributing to this growth during the forecast period include the recent outbreak of infectious diseases, increasing uses in non-communicable diseases, rise in the adoption within home healthcare environments, development in precision medicine initiatives, growth in healthcare infrastructure investments, escalating disease prevalence, and an enhanced understanding of the critical role of early disease detection. Key trends projected throughout this period include the incorporation of artificial intelligence (AI) and machine learning algorithms, progression in molecular diagnostics technologies, downsizing and mobility of POC diagnostic devices, integration with smart devices, and the employment of multiplexing and panel testing in POC diagnostics.

View the full report here:
https://www.thebusinessresearchcompany.com/report/primary-care-poc-diagnostics-global-market-report

What Drivers Are Propelling the Growth of Primary Care POC Diagnostics Market Forward?
Growth in the primary care POC diagnostics market is anticipated to be spurred by the increasing incidence of infectious diseases. Such illnesses, triggered by pathogenic micro-organisms such as bacteria, viruses, fungi, or parasites, can be transmitted either directly between individuals or indirectly via contact with infested surfaces, air, water, or insect vectors. Poor environmental conditions, urbanization, resistance to antimicrobials, and insufficient vaccination coverage all contribute to the prevalence of infectious diseases. In the fight against the spread of infectious diseases, primary care POC diagnostics play a crucial role by enabling quick identification, immediate intervention, and effective measures for disease management in various healthcare contexts. For example, as per a report released in October 2023 by the UK Health Security Agency, a government organization in the UK that oversees public health security, there was a 22% increase in HIV diagnoses in England, up from 3,118 in 2021 to 3,805 in 2022. Additionally, the World Health Organization (WHO), a specialized UN agency based in Switzerland focused on international public health, reported in November 2023 that around 10.6 million tuberculosis (TB) cases occurred worldwide in 2022, affecting 5.8 million men, 3.5 million women, and 1.3 million children. Hence, the escalation in the incidence of infectious diseases is propelling the primary care POC diagnostics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15642&type=smp

Which Emerging Trends Are Transforming the Primary Care POC Diagnostics Market in 2025?
Leading corporations in the primary care POC diagnostics market are honing in on high-tech solutions like portable point-of-care RT-PCR solutions in order to bolster their earnings. These compact, transportable RT-PCR solutions make conducting real-time reverse transcription polymerase chain reaction (RT-PCR) tests a possibility beyond the regular lab environment. For example, in October 2022, Genes2Me Pvt. Ltd., a pioneer in molecular diagnostic solutions from India, rolled out the Rapi-Q Point of Care RT PCR tool meant for diagnosing diseases like HPV and tuberculosis. This solution, with an eight-well block pattern and four fluorescent channels, is touted to be user-friendly and able to deliver quick results in less than 45 minutes. The Rapi-Q system's portability and light weight make it a viable choice for healthcare environments such as hospitals, blood donation centers, health clinics, research labs, and airports. The system scores highly in sensitivity, accuracy, and overall performance in identifying a variety of diseases and works with over 50 lyophilized, room-temperature disease detection kits.

What Are the Key Segments in the Primary Care POC Diagnostics Market?
The primary care POC diagnostics market covered in this report is segmented -

1) By Product: Glucose Monitoring, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy And Fertility Testing Products, Tumor Or Cancer Marker Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drug-Of-Abuse (DOA) Testing Products, Other Products
2) By Prescription: Prescription Based, Over-The-Counter (OTC) Testing
3) By End-Use: Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings, Other End-Uses

Subsegments:
1) By Glucose Monitoring: Blood Glucose Meters, Continuous Glucose Monitoring (Cgm) Systems, Test Strips For Glucose Meters, Glucose Control Solutions
2) By Cardiometabolic Testing Products: Blood Pressure Monitors, Lipid Profile Testing Kits, Hemoglobin A1c Testing Kits, Ecg Or Ecg Monitors, Hba1c Point-Of-Care Devices
3) By Infectious Disease Testing Products: Rapid Strep Tests, Influenza (Flu) Testing Kits, Covid-19 Rapid Tests, Hiv Rapid Testing Kits, Hepatitis Testing Kits, Malaria Rapid Diagnostic Tests (Rdts), Other Infectious Disease Tests
4) By Coagulation Testing Products: Prothrombin Time (Pt) Testing Kits, International Normalized Ratio (Inr) Monitors, Activated Partial Thromboplastin Time (Aptt) Testing Kits, Coagulation Control Solutions, Whole Blood Coagulation Monitors
5) By Pregnancy And Fertility Testing Products: Home Pregnancy Tests (Urine-Based), Ovulation Prediction Kits, Pregnancy Test Strips, Fertility Monitoring Devices
6) By Tumor Or Cancer Marker Testing Products: Psa (Prostate-specific Antigen) Testing Kits, Cea (Carcinoembryonic Antigen) Testing Kits, Ca-125 (Ovarian Cancer Marker) Kits, Her2 Testing Kits, Other Tumor Marker Test Kits
7) By Cholesterol Testing Products: Total Cholesterol Testing Kits, Ldl Or Hdl Testing Kits, Triglyceride Testing Kits, Point-Of-Care Lipid Panel Devices
8) By Hematology Testing Products: Hemoglobin Test Kits, Hematocrit Testing Kits, Complete Blood Count (Cbc) Kits, Point-Of-Care Hematology Analyzers, Hemoglobin A1c Testing Devices
9) By Drug-Of-Abuse (Doa) Testing Products: Urine Drug Tests, Oral Fluid Drug Tests, Saliva-Based Drug Tests, Blood-Based Drug Tests, Breath Alcohol Tests
10) By Other Products: Allergy Testing Kits, Urinalysis Test Strips, Vitamin And Mineral Deficiency Testing Kits, Point-Of-Care Liver Function Tests, Kidney Function Testing Products, Blood Gas Testing Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15642&type=smp

Who Are the Key Players Shaping the Primary Care POC Diagnostics Market's Competitive Landscape?
Major companies operating in the primary care POC diagnostics market are Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers AG, Becton, inson And Company, bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Nova Biomedical Corporation, Randox Laboratories Ltd., Ortho Clinical Diagnostics, Nipro Corporation, OraSure Technologies, Meridian Bioscience Inc., DiaSorin SpA, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Fujirebio Diagnostics Inc., Immunodiagnostic Systems Holdings PLC, Quotient Limited, AccuBioTech Co. Ltd., bioMedomics Inc.

What Geographic Markets Are Powering Growth in the Primary Care POC Diagnostics Market?
North America was the largest region in the primary care POC diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary care POC diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15642

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.